Fairview Capital Investment Management’s Eli Lilly LLY Stock Holding History

Fairview Capital Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Sell	284 -47	-14%	-$47.6K	0.01%	173
2025 Q4	$356K	Buy	331 +5	+2%	+$4.78K	0.02%	138
2025 Q3	$249K	Hold	326	–	–	0.01%	155
2025 Q2	$254K	Sell	326 -80	-20%	-$62.2K	0.01%	146
2025 Q1	$335K	Sell	406 -44	-10%	-$36.6K	0.02%	131
2024 Q4	$347K	Sell	450 -124	-22%	-$103K	0.02%	133
2024 Q3	$509K	Buy	574 +221	+63%	+$199K	0.03%	110
2024 Q2	$320K	Hold	353	–	–	0.02%	122
2024 Q1	$275K	Buy	+353	New	+$251K	0.02%	137
2021 Q3	–	Sell	-1,153	Closed	-$264K	–	129
2021 Q2	$264K	Hold	1,153	–	–	0.02%	112
2021 Q1	$215K	Buy	+1,153	New	+$226K	0.01%	150

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fairview Capital Investment Management's LLY Position: Q1 2026 in Review

Fairview Capital Investment Management reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $47.6K and leaving 284 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #173.

Fairview Capital Investment Management first reported a position in LLY in Q1 2021 and has held it in 11 quarters since. The position peaked at $509K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Fairview Capital Investment Management held 284 shares of Eli Lilly worth $261K as of Q1 2026.
Fairview Capital Investment Management sold 47 Eli Lilly shares in Q1 2026, an estimated $47.6K.
Eli Lilly made up 0.01% of Fairview Capital Investment Management's portfolio in Q1 2026, its #173 holding.
Fairview Capital Investment Management first reported a position in Eli Lilly in Q1 2021 and has held it in 11 quarters since.
Fairview Capital Investment Management's Eli Lilly position peaked at $509K in Q3 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fairview Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.